home / Israel / Protalix BioTherapeutics

Protalix BioTherapeutics Market Cap

$0.20 B

+16.39 M

AMEX:PLX · April 16, 2025

Share price

$2.62

Enterprise Value

$0.18 B

Change (1-Year)

133.9%

Global Rank

#6950

Country Rank

#47

Regions

Israel

Market cap

As of April 16, 2025, Protalix BioTherapeutics (PLX) has a market cap of $0.20 billion USD. According to our data, Protalix BioTherapeutics is ranked No.6950 in global market value.

Sector Rank:

Biotech #431 Pharmaceuticals #393

PLX Market Capitalization Growth

1 Years Growth:

133.9%

3 Years Growth:

108.5%

5 Years Growth:

-24.6%

10 Years Growth:

-86.5%

15 Years Growth:

-96.0%

20 Years Growth:

-83.2%

Total Growth:

-99%

Protalix BioTherapeutics Market Cap Chart

YTD

10Y

15Y

20Y

MAX

Protalix BioTherapeutics Market Cap CAGR Chart

Protalix BioTherapeutics Market Cap History 1998 - 2025

Year	Market Cap	%Change
Apr 16, 2025	$0.20 B	47.69%
Dec 31, 2024	$0.14 B	5.62%
Dec 29, 2023	$0.13 B	29.93%
Dec 30, 2022	$0.10 B	65.06%
Dec 31, 2021	$61.12 M	-77.13%
Dec 31, 2020	$0.27 B	10.67%
Dec 31, 2019	$0.24 B	5.81%
Dec 31, 2018	$0.23 B	-53.03%
Dec 29, 2017	$0.49 B	46.67%
Dec 30, 2016	$0.33 B	-55.88%
Dec 31, 2015	$0.75 B	-44.57%
Dec 31, 2014	$1.35 B	-52.70%
Dec 31, 2013	$2.86 B	-25.05%
Dec 31, 2012	$3.82 B	5.27%
Dec 30, 2011	$3.63 B	-50.60%
Dec 31, 2010	$7.35 B	50.76%
Dec 31, 2009	$4.87 B	259.78%
Dec 31, 2008	$1.35 B	-45.88%
Dec 31, 2007	$2.50 B	-79.64%
Dec 29, 2006	$12.30 B	-60.71%
Dec 30, 2005	$31.29 B	2,025.00%
Dec 31, 2004	$1.47 B	-50.00%
Dec 31, 2003	$2.95 B	263.64%
Dec 31, 2002	$0.81 B	-52.17%
Dec 31, 2001	$1.69 B	22.67%
Dec 29, 2000	$1.38 B	-78.57%
Dec 31, 1999	$6.44 B	-61.11%
Dec 31, 1998	$16.57 B	100%

Similar Companies to Protalix BioTherapeutics

Name	Market Cap	Market cap difference	Regions
Amicus Therapeutics FOLD	$2.12 B	-0.000 M	USA
BioMarin Pharmaceutical BMRN	$11.51 B	-0.000 M	USA
Ultragenyx RARE	$3.32 B	0.000 M	USA
Sangamo Therapeutics SGMO	$0.17 B	0.000 M	USA
Sarepta Therapeutics SRPT	$5.28 B	-0.000 M	USA
REGENXBIO RGNX	$0.33 B	-0.000 M	USA
Voyager Therapeutics VYGR	$0.18 B	-0.000 M	USA
bluebird bio BLUE	$43.76 M	0.000 M	USA
uniQure QURE	$0.52 B	0.000 M	Netherlands
Editas Medicine EDIT	$0.11 B	0.000 M	USA
CRISPR Therapeutics CRSP	$3.34 B	0.000 M	Switzerland
Intellia Therapeutics NTLA	$0.76 B	-0.000 M	USA

About Protalix BioTherapeutics Inc.

Name

Protalix BioTherapeutics, Inc.

Website

https://www.protalix.com

Headquarters

Hackensack,NJ

symbol

PLX

CURRENCY

USD

country

Israel

fullTimeEmployees

213

exchange

ASE

firstTradeDateEpochUtc

1969/12/31

PLX Market Cap Formula

Market Cap	=	PLX Stock Price	*	PLX Shares Outstanding
	=	$2.62	*	78.03 M
	=	$0.20 B

What is Market Cap?

Market capitalization represents the market's valuation of a company, calculated by multiplying the current share price by the total number of outstanding shares. It helps to assess the company's size and allows for comparison with other companies.

Material

wikipedia Share_price outstanding

What is Market Capitalization?

Market capitalization, or market cap, is a key measure of a company's market value. It is calculated by multiplying the current stock price by the total number of outstanding shares. Market cap is often used by investors to assess a company's size, stability, and market presence. For any inquiries or to report an issue, please email us at [email protected].

Disclaimer

This website provides general information only. While we aim for accuracy, we do not guarantee data completeness or reliability. Consult a financial advisor before investing. We are not responsible for any losses or damages from using this site. By using it, you agree to these terms. Company logos belong to their respective copyright holders and are shown for editorial purposes only. Prices are not in real time.

America

Europe